DANIEL RICHARD LEWIS
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SAN LUIS OBISPO, CA NPI 1598749079
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CA Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$2,004.05
- Category: General Payments
- Program years: PY2018–2024
- Record count: 103
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,213.02 across 61 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,213.02 | 61 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $171.66 | 8 |
| Janssen Biotech, Inc. | $131.70 | 7 |
| ABBVIE INC. | $94.40 | 5 |
| PFIZER INC. | $84.64 | 4 |
| Exelixis Inc. | $78.05 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $60.70 | 3 |
| Acerta Pharma LLC | $54.77 | 3 |
| Celgene Corporation | $54.01 | 3 |
| GlaxoSmithKline, LLC. | $53.23 | 2 |
| BeiGene USA, Inc. | $51.54 | 3 |
| Deciphera Pharmaceuticals Inc. | $42.91 | 2 |
| Alnylam Pharmaceuticals Inc. | $39.94 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.53 | 2 |
| Stemline Therapeutics Inc. | $39.00 | 1 |
| ADC Therapeutics America, Inc. | $34.30 | 1 |
| SOBI, INC | $27.78 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.98 | 1 |
| EMD Serono, Inc. | $21.84 | 1 |
| Rigel Pharmaceuticals, Inc. | $20.10 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.28 | 1 |
| MorphoSys, US Inc. | $15.58 | 1 |
| Genentech USA, Inc. | $15.12 | 1 |
| EISAI INC. | $13.90 | 1 |
| Gilead Sciences, Inc. | $13.58 | 1 |
| ARRAY BIOPHARMA INC | $13.48 | 1 |
By program year
Records — PY2024 (61)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.